The mania-like exploratory profile in genetic dopamine transporter mouse models is diminished in a familiar environment and reinstated by subthreshold psychostimulant administration
- PMID: 20363246
- PMCID: PMC2878916
- DOI: 10.1016/j.pbb.2010.03.014
The mania-like exploratory profile in genetic dopamine transporter mouse models is diminished in a familiar environment and reinstated by subthreshold psychostimulant administration
Abstract
Bipolar Disorder (BD) is a neuropsychiatric disorder characterized by symptoms ranging from a hyperactive manic state to depression, with periods of relative stability, known as euthymia, in between. Although prognosis for BD sufferers remains poor, treatment development has been restricted due to a paucity of validated animal models. Moreover, most models focus on the manic state of BD with little done to characterize the longitudinal behavior of these models. We recently presented two dopamine transporter (DAT) mouse models of BD mania: genetic (DAT knockdown; KD, mice) and pharmacological (the selective DAT inhibitor GBR 12909). These models exhibit an exploratory profile consistent with the quantified exploratory profile of manic BD patients observed in the cross-species translational test, the Behavioral Pattern Monitor (BPM). To further explore the suitability of these models, we examined the effects of reduced DAT function on the behavior of mice tested after familiarization to the BPM environment. Testing with 16mg/kg GBR 12909 in familiarized mice resulted in a consistent mania-like profile. In contrast, the mania-like profile of DAT KD mice disappears in a familiar environment, with partial reinstatement elicited by the introduction of novelty. In addition, we found that a subthreshold dose of GBR 12909 (9mg/kg) reinstated the mania-like profile in DAT KD mice without affecting wildtype behavior. Thus, the mania-like exploratory profile of DAT KD mice is reduced in a familiar environment, partially reinstated with novelty, but is fully restored when administered a stimulant that is ineffective in wildtype mice. These mice may provide a model of BD from mania to euthymia and back again with stimulant treatment. Acute blockade of the DAT by GBR 12909 however, may provide a consistent model for BD mania.
Copyright 2010 Elsevier Inc. All rights reserved.
Figures






Similar articles
-
GBR 12909 administration as a mouse model of bipolar disorder mania: mimicking quantitative assessment of manic behavior.Psychopharmacology (Berl). 2010 Feb;208(3):443-54. doi: 10.1007/s00213-009-1744-8. Epub 2009 Dec 18. Psychopharmacology (Berl). 2010. PMID: 20020109 Free PMC article.
-
Increased risk-taking behavior in dopamine transporter knockdown mice: further support for a mouse model of mania.J Psychopharmacol. 2011 Jul;25(7):934-43. doi: 10.1177/0269881111400646. Epub 2011 Mar 18. J Psychopharmacol. 2011. PMID: 21421642 Free PMC article.
-
Brexpiprazole reduces hyperactivity, impulsivity, and risk-preference behavior in mice with dopamine transporter knockdown-a model of mania.Psychopharmacology (Berl). 2017 Mar;234(6):1017-1028. doi: 10.1007/s00213-017-4543-7. Epub 2017 Feb 3. Psychopharmacology (Berl). 2017. PMID: 28160035 Free PMC article.
-
A reverse-translational approach to bipolar disorder: rodent and human studies in the Behavioral Pattern Monitor.Neurosci Biobehav Rev. 2007;31(6):882-96. doi: 10.1016/j.neubiorev.2007.05.009. Epub 2007 Jun 5. Neurosci Biobehav Rev. 2007. PMID: 17706782 Free PMC article. Review.
-
The dopamine transporter inhibition using GBR 12909 as a novel pharmacological tool to assess bipolar disorder-like neurobehavioral phenotypes in zebrafish.Behav Brain Res. 2025 Feb 4;477:115302. doi: 10.1016/j.bbr.2024.115302. Epub 2024 Oct 21. Behav Brain Res. 2025. PMID: 39442564 Review.
Cited by
-
Differential effects of dopamine transporter inhibitors in the rodent Iowa gambling task: relevance to mania.Psychopharmacology (Berl). 2013 Feb;225(3):661-74. doi: 10.1007/s00213-012-2854-2. Epub 2012 Sep 4. Psychopharmacology (Berl). 2013. PMID: 22945515 Free PMC article.
-
The catecholaminergic-cholinergic balance hypothesis of bipolar disorder revisited.Eur J Pharmacol. 2015 Apr 15;753:114-26. doi: 10.1016/j.ejphar.2014.05.063. Epub 2014 Aug 5. Eur J Pharmacol. 2015. PMID: 25107282 Free PMC article. Review.
-
Dopamine transporter knockdown mice in the behavioral pattern monitor: A robust, reproducible model for mania-relevant behaviors.Pharmacol Biochem Behav. 2019 Mar;178:42-50. doi: 10.1016/j.pbb.2017.12.007. Epub 2017 Dec 28. Pharmacol Biochem Behav. 2019. PMID: 29289701 Free PMC article.
-
The behavioral activation system and mania.Annu Rev Clin Psychol. 2012;8:243-67. doi: 10.1146/annurev-clinpsy-032511-143148. Epub 2011 Nov 7. Annu Rev Clin Psychol. 2012. PMID: 22077912 Free PMC article. Review.
-
Chronic nicotine, but not suramin or resveratrol, partially remediates the mania-like profile of dopamine transporter knockdown mice.Eur Neuropsychopharmacol. 2021 Jan;42:75-86. doi: 10.1016/j.euroneuro.2020.11.004. Epub 2020 Nov 13. Eur Neuropsychopharmacol. 2021. PMID: 33191077 Free PMC article.
References
-
- Adida M, Clark L, Pomietto P, Kaladjian A, Besnier N, Azorin JM, et al. Lack of insight may predict impaired decision making in manic patients. Bipolar disorders. 2008;10:829–37. - PubMed
-
- Amsterdam JD, Newberg AB. A preliminary study of dopamine transporter binding in bipolar and unipolar depressed patients and healthy controls. Neuropsychobiology. 2007;55:167–70. - PubMed
-
- Benedetti F, Serretti A, Colombo C, Barbini B, Lorenzi C, Campori E, et al. Influence of CLOCK gene polymorphism on circadian mood fluctuation and illness recurrence in bipolar depression. Am J Med Genet B Neuropsychiatr Genet. 2003;123B:23–6. - PubMed
-
- Cagniard B, Balsam PD, Brunner D, Zhuang X. Mice with chronically elevated dopamine exhibit enhanced motivation, but not learning, for a food reward. Neuropsychopharmacology. 2006;31:1362–70. - PubMed
-
- Clark L, Iversen SD, Goodwin GM. A neuropsychological investigation of prefrontal cortex involvement in acute mania. The American journal of psychiatry. 2001;158:1605–11. - PubMed